Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Migraine: Genetic Variants and Clinical Phenotypes

Author(s): Innocenzo Rainero*, Alessandro Vacca, Flora Govone, Annalisa Gai, Lorenzo Pinessi and Elisa Rubino

Volume 26, Issue 34, 2019

Page: [6207 - 6221] Pages: 15

DOI: 10.2174/0929867325666180719120215

Price: $65

Abstract

Migraine is a common, chronic neurovascular disorder caused by a complex interaction between genetic and environmental risk factors. In the last two decades, molecular genetics of migraine have been intensively investigated. In a few cases, migraine is transmitted as a monogenic disorder, and the disease phenotype cosegregates with mutations in different genes like CACNA1A, ATP1A2, SCN1A, KCNK18, and NOTCH3. In the common forms of migraine, candidate genes as well as genome-wide association studies have shown that a large number of genetic variants may increase the risk of developing migraine. At present, few studies investigated the genotype-phenotype correlation in patients with migraine. The purpose of this review was to discuss recent studies investigating the relationship between different genetic variants and the clinical characteristics of migraine. Analysis of genotype-phenotype correlations in migraineurs is complicated by several confounding factors and, to date, only polymorphisms of the MTHFR gene have been shown to have an effect on migraine phenotype. Additional genomic studies and network analyses are needed to clarify the complex pathways underlying migraine and its clinical phenotypes.

Keywords: Migraine, gene, CACNA1A, ATP1A2, SCN1A, KCNK18.

[1]
Tfelt-Hansen, P.C.; Koehler, P.J. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. Headache, 2011, 51(5), 752-778.
[http://dx.doi.org/10.1111/j.1526-4610.2011.01892.x] [PMID: 21521208]
[2]
Bigal, M.E.; Lipton, R.B. The epidemiology, burden, and comorbidities of migraine. Neurol. Clin., 2009, 27(2), 321-334.
[http://dx.doi.org/10.1016/j.ncl.2008.11.011] [PMID: 19289218]
[3]
Vos, T.; Flaxman, A.D.; Naghavi, M.; Lozano, R.; Michaud, C.; Ezzati, M.; Shibuya, K.; Salomon, J.A.; Abdalla, S.; Aboyans, V.; Abraham, J.; Ackerman, I.; Aggarwal, R.; Ahn, S.Y.; Ali, M.K.; Alvarado, M.; Anderson, H.R.; Anderson, L.M.; Andrews, K.G.; Atkinson, C.; Baddour, L.M.; Bahalim, A.N.; Barker-Collo, S.; Barrero, L.H.; Bartels, D.H.; Basáñez, M.G.; Baxter, A.; Bell, M.L.; Benjamin, E.J.; Bennett, D.; Bernabé, E.; Bhalla, K.; Bhandari, B.; Bikbov, B.; Bin Abdulhak, A.; Birbeck, G.; Black, J.A.; Blencowe, H.; Blore, J.D.; Blyth, F.; Bolliger, I.; Bonaventure, A.; Boufous, S.; Bourne, R.; Boussinesq, M.; Braithwaite, T.; Brayne, C.; Bridgett, L.; Brooker, S.; Brooks, P.; Brugha, T.S.; Bryan-Hancock, C.; Bucello, C.; Buchbinder, R.; Buckle, G.; Budke, C.M.; Burch, M.; Burney, P.; Burstein, R.; Calabria, B.; Campbell, B.; Canter, C.E.; Carabin, H.; Carapetis, J.; Carmona, L.; Cella, C.; Charlson, F.; Chen, H.; Cheng, A.T.; Chou, D.; Chugh, S.S.; Coffeng, L.E.; Colan, S.D.; Colquhoun, S.; Colson, K.E.; Condon, J.; Connor, M.D.; Cooper, L.T.; Corriere, M.; Cortinovis, M.; de Vaccaro, K.C.; Couser, W.; Cowie, B.C.; Criqui, M.H.; Cross, M.; Dabhadkar, K.C.; Dahiya, M.; Dahodwala, N.; Damsere-Derry, J.; Danaei, G.; Davis, A.; De Leo, D.; Degenhardt, L.; Dellavalle, R.; Delossantos, A.; Denenberg, J.; Derrett, S.; Des Jarlais, D.C.; Dharmaratne, S.D.; Dherani, M.; Diaz-Torne, C.; Dolk, H.; Dorsey, E.R.; Driscoll, T.; Duber, H.; Ebel, B.; Edmond, K.; Elbaz, A.; Ali, S.E.; Erskine, H.; Erwin, P.J.; Espindola, P.; Ewoigbokhan, S.E.; Farzadfar, F.; Feigin, V.; Felson, D.T.; Ferrari, A.; Ferri, C.P.; Fèvre, E.M.; Finucane, M.M.; Flaxman, S.; Flood, L.; Foreman, K.; Forouzanfar, M.H.; Fowkes, F.G.; Franklin, R.; Fransen, M.; Freeman, M.K.; Gabbe, B.J.; Gabriel, S.E.; Gakidou, E.; Ganatra, H.A.; Garcia, B.; Gaspari, F.; Gillum, R.F.; Gmel, G.; Gosselin, R.; Grainger, R.; Groeger, J.; Guillemin, F.; Gunnell, D.; Gupta, R.; Haagsma, J.; Hagan, H.; Halasa, Y.A.; Hall, W.; Haring, D.; Haro, J.M.; Harrison, J.E.; Havmoeller, R.; Hay, R.J.; Higashi, H.; Hill, C.; Hoen, B.; Hoffman, H.; Hotez, P.J.; Hoy, D.; Huang, J.J.; Ibeanusi, S.E.; Jacobsen, K.H.; James, S.L.; Jarvis, D.; Jasrasaria, R.; Jayaraman, S.; Johns, N.; Jonas, J.B.; Karthikeyan, G.; Kassebaum, N.; Kawakami, N.; Keren, A.; Khoo, J.P.; King, C.H.; Knowlton, L.M.; Kobusingye, O.; Koranteng, A.; Krishnamurthi, R.; Lalloo, R.; Laslett, L.L.; Lathlean, T.; Leasher, J.L.; Lee, Y.Y.; Leigh, J.; Lim, S.S.; Limb, E.; Lin, J.K.; Lipnick, M.; Lipshultz, S.E.; Liu, W.; Loane, M.; Ohno, S.L.; Lyons, R.; Ma, J.; Mabweijano, J.; MacIntyre, M.F.; Malekzadeh, R.; Mallinger, L.; Manivannan, S.; Marcenes, W.; March, L.; Margolis, D.J.; Marks, G.B.; Marks, R.; Matsumori, A.; Matzopoulos, R.; Mayosi, B.M.; McAnulty, J.H.; McDermott, M.M.; McGill, N.; McGrath, J.; Medina-Mora, M.E.; Meltzer, M.; Mensah, G.A.; Merriman, T.R.; Meyer, A.C.; Miglioli, V.; Miller, M.; Miller, T.R.; Mitchell, P.B.; Mocumbi, A.O.; Moffitt, T.E.; Mokdad, A.A.; Monasta, L.; Montico, M.; Moradi-Lakeh, M.; Moran, A.; Morawska, L.; Mori, R.; Murdoch, M.E.; Mwaniki, M.K.; Naidoo, K.; Nair, M.N.; Naldi, L.; Narayan, K.M.; Nelson, P.K.; Nelson, R.G.; Nevitt, M.C.; Newton, C.R.; Nolte, S.; Norman, P.; Norman, R.; O’Donnell, M.; O’Hanlon, S.; Olives, C.; Omer, S.B.; Ortblad, K.; Osborne, R.; Ozgediz, D.; Page, A.; Pahari, B.; Pandian, J.D.; Rivero, A.P.; Patten, S.B.; Pearce, N.; Padilla, R.P.; Perez-Ruiz, F.; Perico, N.; Pesudovs, K.; Phillips, D.; Phillips, M.R.; Pierce, K.; Pion, S.; Polanczyk, G.V.; Polinder, S.; Pope, C.A., III; Popova, S.; Porrini, E.; Pourmalek, F.; Prince, M.; Pullan, R.L.; Ramaiah, K.D.; Ranganathan, D.; Razavi, H.; Regan, M.; Rehm, J.T.; Rein, D.B.; Remuzzi, G.; Richardson, K.; Rivara, F.P.; Roberts, T.; Robinson, C.; De Leòn, F.R.; Ronfani, L.; Room, R.; Rosenfeld, L.C.; Rushton, L.; Sacco, R.L.; Saha, S.; Sampson, U.; Sanchez-Riera, L.; Sanman, E.; Schwebel, D.C.; Scott, J.G.; Segui-Gomez, M.; Shahraz, S.; Shepard, D.S.; Shin, H.; Shivakoti, R.; Singh, D.; Singh, G.M.; Singh, J.A.; Singleton, J.; Sleet, D.A.; Sliwa, K.; Smith, E.; Smith, J.L.; Stapelberg, N.J.; Steer, A.; Steiner, T.; Stolk, W.A.; Stovner, L.J.; Sudfeld, C.; Syed, S.; Tamburlini, G.; Tavakkoli, M.; Taylor, H.R.; Taylor, J.A.; Taylor, W.J.; Thomas, B.; Thomson, W.M.; Thurston, G.D.; Tleyjeh, I.M.; Tonelli, M.; Towbin, J.A.; Truelsen, T.; Tsilimbaris, M.K.; Ubeda, C.; Undurraga, E.A.; van der Werf, M.J.; van Os, J.; Vavilala, M.S.; Venketasubramanian, N.; Wang, M.; Wang, W.; Watt, K.; Weatherall, D.J.; Weinstock, M.A.; Weintraub, R.; Weisskopf, M.G.; Weissman, M.M.; White, R.A.; Whiteford, H.; Wiersma, S.T.; Wilkinson, J.D.; Williams, H.C.; Williams, S.R.; Witt, E.; Wolfe, F.; Woolf, A.D.; Wulf, S.; Yeh, P.H.; Zaidi, A.K.; Zheng, Z.J.; Zonies, D.; Lopez, A.D.; Murray, C.J.; AlMazroa, M.A.; Memish, Z.A. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global burden of disease study 2010. Lancet, 2012, 380(9859), 2163-2196.
[http://dx.doi.org/10.1016/S0140-6736(12)61729-2] [PMID: 23245607]
[4]
Steiner, T.J.; Stovner, L.J.; Vos, T. GBD 2015: migraine is the third cause of disability in under 50s. J. Headache Pain, 2016, 17(1), 104.
[http://dx.doi.org/10.1186/s10194-016-0699-5] [PMID: 27844455]
[5]
Bonafede, M.; Sapra, S.; Shah, N.; Tepper, S.; Cappell, K.; Desai, P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache, 2018, 58(5), 700-714.
[http://dx.doi.org/10.1111/head.13275] [PMID: 29446063]
[6]
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders 3rd edition Cephalalgia,, 2018, 38(1), 1-211.
[http://dx.doi.org/10.1177/0333102417738202] [PMID: 29368949]
[7]
Minen, M.T.; Begasse De Dhaem, O.; Kroon Van Diest, A.; Powers, S.; Schwedt, T.J.; Lipton, R.; Silbersweig, D. Migraine and its psychiatric comorbidities. J. Neurol. Neurosurg. Psychiatry, 2016, 87(7), 741-749.
[http://dx.doi.org/10.1136/jnnp-2015-312233] [PMID: 26733600]
[8]
Rainero, I.; Govone, F.; Gai, A.; Vacca, A.; Rubino, E. Is Migraine primarily a metaboloendocrine disorder? Curr. Pain Headache Rep., 2018, 22(5), 36.
[http://dx.doi.org/10.1007/s11916-018-0691-7] [PMID: 29619630]
[9]
Scher, A.I.; Bigal, M.E.; Lipton, R.B. Comorbidity of migraine. Curr. Opin. Neurol., 2005, 18(3), 305-310.
[http://dx.doi.org/10.1097/01.wco.0000169750.52406.a2] [PMID: 15891417]
[10]
Schwedt, T.J. The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol. Clin., 2009, 27(2), 513-523.
[http://dx.doi.org/10.1016/j.ncl.2008.11.006] [PMID: 19289229]
[11]
Mulder, E.J.; Van Baal, C.; Gaist, D.; Kallela, M.; Kaprio, J.; Svensson, D.A.; Nyholt, D.R.; Martin, N.G.; MacGregor, A.J.; Cherkas, L.F.; Boomsma, D.I.; Palotie, A. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res., 2003, 6(5), 422-431.
[http://dx.doi.org/10.1375/136905203770326420] [PMID: 14624726]
[12]
Svensson, D.A.; Larsson, B.; Waldenlind, E.; Pedersen, N.L. Shared rearing environment in migraine: results from twins reared apart and twins reared together. Headache, 2003, 43(3), 235-244.
[http://dx.doi.org/10.1046/j.1526-4610.2003.03047.x] [PMID: 12603642]
[13]
Russell, M.B.; Ulrich, V.; Gervil, M.; Olesen, J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache, 2002, 42(5), 332-336.
[http://dx.doi.org/10.1046/j.1526-4610.2002.02102.x] [PMID: 12047331]
[14]
Montagna, P. Migraine genetics. Expert Rev. Neurother., 2008, 8(9), 1321-1330.
[http://dx.doi.org/10.1586/14737175.8.9.1321] [PMID: 18759544]
[15]
Tolner, E.A.; Houben, T.; Terwindt, G.M.; de Vries, B.; Ferrari, M.D.; van den Maagdenberg, A.M. From migraine genes to mechanisms. Pain, 2015, 156(Suppl. 1), S64-S74.
[http://dx.doi.org/10.1097/01.j.pain.0000460346.00213.16] [PMID: 25789438]
[16]
Pietrobon, D. Familial hemiplegic migraine. Neurotherapeutics, 2007, 4(2), 274-284.
[http://dx.doi.org/10.1016/j.nurt.2007.01.008] [PMID: 17395138]
[17]
Liem, M.K.; Oberstein, S.A.; van der Grond, J.; Ferrari, M.D.; Haan, J. CADASIL and migraine: A narrative review. Cephalalgia, 2010, 30(11), 1284-1289.
[http://dx.doi.org/10.1177/0333102410370870] [PMID: 21038489]
[18]
Xu, Y.; Padiath, Q.S.; Shapiro, R.E.; Jones, C.R.; Wu, S.C.; Saigoh, N.; Saigoh, K.; Ptácek, L.J.; Fu, Y.H. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature, 2005, 434(7033), 640-644.
[http://dx.doi.org/10.1038/nature03453] [PMID: 15800623]
[19]
Stam, A.H.; Kothari, P.H.; Shaikh, A.; Gschwendter, A.; Jen, J.C.; Hodgkinson, S.; Hardy, T.A.; Hayes, M.; Kempster, P.A.; Kotschet, K.E.; Bajema, I.M.; van Duinen, S.G.; Maat-Schieman, M.L.C.; de Jong, P.T.V.M.; de Smet, M.D.; de Wolff-Rouendaal, D.; Dijkman, G.; Pelzer, N.; Kolar, G.R.; Schmidt, R.E.; Lacey, J.; Joseph, D.; Fintak, D.R.; Grand, M.G.; Brunt, E.M.; Liapis, H.; Hajj-Ali, R.A.; Kruit, M.C.; van Buchem, M.A.; Dichgans, M.; Frants, R.R.; van den Maagdenberg, A.M.J.M.; Haan, J.; Baloh, R.W.; Atkinson, J.P.; Terwindt, G.M.; Ferrari, M.D. Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain, 2016, 139(11), 2909-2922.
[http://dx.doi.org/10.1093/brain/aww217] [PMID: 27604306]
[20]
Kowalska, M.; Prendecki, M.; Kozubski, W.; Lianeri, M.; Dorszewska, J. Molecular factors in migraine. Oncotarget, 2016, 7(31), 50708-50718.
[http://dx.doi.org/10.18632/oncotarget.9367] [PMID: 27191890]
[21]
Anttila, V.; Wessman, M.; Kallela, M.; Palotie, A. Genetics of migraine. Handb. Clin. Neurol., 2018, 148, 493-503.
[http://dx.doi.org/10.1016/B978-0-444-64076-5.00031-4] [PMID: 29478595]
[22]
Ophoff, R.A.; Terwindt, G.M.; Vergouwe, M.N.; van Eijk, R.; Oefner, P.J.; Hoffman, S.M.; Lamerdin, J.E.; Mohrenweiser, H.W.; Bulman, D.E.; Ferrari, M.; Haan, J.; Lindhout, D.; van Ommen, G.J.; Hofker, M.H.; Ferrari, M.D.; Frants, R.R. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell, 1996, 87(3), 543-552.
[http://dx.doi.org/10.1016/S0092-8674(00)81373-2] [PMID: 8898206]
[23]
De Fusco, M.; Marconi, R.; Silvestri, L.; Atorino, L.; Rampoldi, L.; Morgante, L.; Ballabio, A.; Aridon, P.; Casari, G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet., 2003, 33(2), 192-196.
[http://dx.doi.org/10.1038/ng1081] [PMID: 12539047]
[24]
Dichgans, M.; Freilinger, T.; Eckstein, G.; Babini, E.; Lorenz-Depiereux, B.; Biskup, S.; Ferrari, M.D.; Herzog, J.; van den Maagdenberg, A.M.; Pusch, M.; Strom, T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet, 2005, 366(9483), 371-377.
[http://dx.doi.org/10.1016/S0140-6736(05)66786-4] [PMID: 16054936]
[25]
Hiekkala, M.E.; Vuola, P.; Artto, V.; Häppölä, P.; Häppölä, E.; Vepsäläinen, S.; Cuenca-León, E.; Lal, D.; Gormley, P.; Hämäläinen, E.; Ilmavirta, M.; Nissilä, M.; Säkö, E.; Sumelahti, M.L.; Harno, H.; Havanka, H.; Keski-Säntti, P.; Färkkilä, M.; Palotie, A.; Wessman, M.; Kaunisto, M.A.; Kallela, M. The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families. Cephalalgia, 2018, 38(12), 1849-1863.
[http://dx.doi.org/10.1177/0333102418761041] [PMID: 29486580]
[26]
Lafrenière, R.G.; Cader, M.Z.; Poulin, J.F.; Andres-Enguix, I.; Simoneau, M.; Gupta, N.; Boisvert, K.; Lafrenière, F.; McLaughlan, S.; Dubé, M.P.; Marcinkiewicz, M.M.; Ramagopalan, S.; Ansorge, O.; Brais, B.; Sequeiros, J.; Pereira-Monteiro, J.M.; Griffiths, L.R.; Tucker, S.J.; Ebers, G.; Rouleau, G.A. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat. Med., 2010, 16(10), 1157-1160.
[http://dx.doi.org/10.1038/nm.2216] [PMID: 20871611]
[27]
Menon, S.; Cox, H.C.; Kuwahata, M.; Quinlan, S.; MacMillan, J.C.; Haupt, L.M.; Lea, R.A.; Griffiths, L.R. Association of a Notch 3 gene polymorphism with migraine susceptibility. Cephalalgia, 2011, 31(3), 264-270.
[http://dx.doi.org/10.1177/0333102410381143] [PMID: 20813781]
[28]
Sheerin, U.M.; Stamelou, M.; Charlesworth, G.; Shiner, T.; Spacey, S.; Valente, E.M.; Wood, N.W.; Bhatia, K.P. Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation. J. Neurol., 2013, 260(2), 656-660.
[http://dx.doi.org/10.1007/s00415-012-6747-4] [PMID: 23180180]
[29]
Richards, A.; van den Maagdenberg, A.M.; Jen, J.C.; Kavanagh, D.; Bertram, P.; Spitzer, D.; Liszewski, M.K.; Barilla-Labarca, M.L.; Terwindt, G.M.; Kasai, Y.; McLellan, M.; Grand, M.G.; Vanmolkot, K.R.; de Vries, B.; Wan, J.; Kane, M.J.; Mamsa, H.; Schäfer, R.; Stam, A.H.; Haan, J.; de Jong, P.T.; Storimans, C.W.; van Schooneveld, M.J.; Oosterhuis, J.A.; Gschwendter, A.; Dichgans, M.; Kotschet, K.E.; Hodgkinson, S.; Hardy, T.A.; Delatycki, M.B.; Hajj-Ali, R.A.; Kothari, P.H.; Nelson, S.F.; Frants, R.R.; Baloh, R.W.; Ferrari, M.D.; Atkinson, J.P. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat. Genet., 2007, 39(9), 1068-1070.
[http://dx.doi.org/10.1038/ng2082] [PMID: 17660820]
[30]
Nagata, E.; Fujii, N.; Hosomichi, K.; Mitsunaga, S.; Suzuki, Y.; Mashimo, Y.; Tsukamoto, H.; Satoh, T.; Osawa, M.; Inoue, I.; Hata, A.; Takizawa, S. Possible association between dysfunction of vitamin D binding protein (GC Globulin) and migraine attacks. PLoS One, 2014, 9(8)e105319
[http://dx.doi.org/10.1371/journal.pone.0105319] [PMID: 25147936]
[31]
Suzuki, M.; Van Paesschen, W.; Stalmans, I.; Horita, S.; Yamada, H.; Bergmans, B.A.; Legius, E.; Riant, F.; De Jonghe, P.; Li, Y.; Sekine, T.; Igarashi, T.; Fujimoto, I.; Mikoshiba, K.; Shimadzu, M.; Shiohara, M.; Braverman, N.; Al-Gazali, L.; Fujita, T.; Seki, G. Defective membrane expression of the Na(+)-HCO(3)(-) cotransporter NBCe1 is associated with familial migraine. Proc. Natl. Acad. Sci. USA, 2010, 107(36), 15963-15968.
[http://dx.doi.org/10.1073/pnas.1008705107] [PMID: 20798035]
[32]
Kondratieva, N.; Azimova, J.; Skorobogatykh, K.; Sergeev, A.; Naumova, E.; Kokaeva, Z.; Anuchina, A.; Rudko, O.; Tabeeva, G.; Klimov, E. Biomarkers of migraine: Part 1 - genetic markers. J. Neurol. Sci., 2016, 369, 63-76.
[http://dx.doi.org/10.1016/j.jns.2016.08.008] [PMID: 27653868]
[33]
Gasparini, C.F.; Sutherland, H.G.; Griffiths, L.R. Studies on the pathophysiology and genetic basis of migraine. Curr. Genomics, 2013, 14(5), 300-315.
[http://dx.doi.org/10.2174/13892029113149990007] [PMID: 24403849]
[34]
De Marchis, M.L.; Barbanti, P.; Palmirotta, R.; Egeo, G.; Aurilia, C.; Fofi, L.; Piroso, S.; Ialongo, C.; Della-Morte, D.; D’Andrea, G.; Ferroni, P.; Guadagni, F. Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study. J. Headache Pain, 2015, 16, 520.
[http://dx.doi.org/10.1186/s10194-015-0520-x] [PMID: 25929431]
[35]
Rainero, I.; Rubino, E.; Paemeleire, K.; Gai, A.; Vacca, A.; De Martino, P.; Gentile, S.; Sarchielli, P.; Pinessi, L. Genes and primary headaches: discovering new potential therapeutic targets. J. Headache Pain, 2013, 14, 61.
[http://dx.doi.org/10.1186/1129-2377-14-61] [PMID: 23848401]
[36]
Schürks, M.; Rist, P.M.; Kurth, T. Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis. Cephalalgia, 2010, 30(11), 1306-1328.
[http://dx.doi.org/10.1177/0333102410364155] [PMID: 20959426]
[37]
Gormley, P.; Anttila, V.; Winsvold, B.S.; Palta, P.; Esko, T.; Pers, T.H.; Farh, K.H.; Cuenca-Leon, E.; Muona, M.; Furlotte, N.A.; Kurth, T.; Ingason, A.; McMahon, G.; Ligthart, L.; Terwindt, G.M.; Kallela, M.; Freilinger, T.M.; Ran, C.; Gordon, S.G.; Stam, A.H.; Steinberg, S.; Borck, G.; Koiranen, M.; Quaye, L.; Adams, H.H.; Lehtimäki, T.; Sarin, A.P.; Wedenoja, J.; Hinds, D.A.; Buring, J.E.; Schürks, M.; Ridker, P.M.; Hrafnsdottir, M.G.; Stefansson, H.; Ring, S.M.; Hottenga, J.J.; Penninx, B.W.; Färkkilä, M.; Artto, V.; Kaunisto, M.; Vepsäläinen, S.; Malik, R.; Heath, A.C.; Madden, P.A.; Martin, N.G.; Montgomery, G.W.; Kurki, M.I.; Kals, M.; Mägi, R.; Pärn, K.; Hämäläinen, E.; Huang, H.; Byrnes, A.E.; Franke, L.; Huang, J.; Stergiakouli, E.; Lee, P.H.; Sandor, C.; Webber, C.; Cader, Z.; Muller-Myhsok, B.; Schreiber, S.; Meitinger, T.; Eriksson, J.G.; Salomaa, V.; Heikkilä, K.; Loehrer, E.; Uitterlinden, A.G.; Hofman, A.; van Duijn, C.M.; Cherkas, L.; Pedersen, L.M.; Stubhaug, A.; Nielsen, C.S.; Männikkö, M.; Mihailov, E.; Milani, L.; Göbel, H.; Esserlind, A.L.; Christensen, A.F.; Hansen, T.F.; Werge, T.; Kaprio, J.; Aromaa, A.J.; Raitakari, O.; Ikram, M.A.; Spector, T.; Järvelin, M.R.; Metspalu, A.; Kubisch, C.; Strachan, D.P.; Ferrari, M.D.; Belin, A.C.; Dichgans, M.; Wessman, M.; van den Maagdenberg, A.M.; Zwart, J.A.; Boomsma, D.I.; Smith, G.D.; Stefansson, K.; Eriksson, N.; Daly, M.J.; Neale, B.M.; Olesen, J.; Chasman, D.I.; Nyholt, D.R.; Palotie, A. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet., 2016, 48(8), 856-866.
[http://dx.doi.org/10.1038/ng.3598] [PMID: 27322543]
[38]
Chasman, D.I.; Schürks, M.; Anttila, V.; de Vries, B.; Schminke, U.; Launer, L.J.; Terwindt, G.M.; van den Maagdenberg, A.M.; Fendrich, K.; Völzke, H.; Ernst, F.; Griffiths, L.R.; Buring, J.E.; Kallela, M.; Freilinger, T.; Kubisch, C.; Ridker, P.M.; Palotie, A.; Ferrari, M.D.; Hoffmann, W.; Zee, R.Y.; Kurth, T. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet., 2011, 43(7), 695-698.
[http://dx.doi.org/10.1038/ng.856] [PMID: 21666692]
[39]
Anttila, V.; Winsvold, B.S.; Gormley, P.; Kurth, T.; Bettella, F.; McMahon, G.; Kallela, M.; Malik, R.; de Vries, B.; Terwindt, G.; Medland, S.E.; Todt, U.; McArdle, W.L.; Quaye, L.; Koiranen, M.; Ikram, M.A.; Lehtimäki, T.; Stam, A.H.; Ligthart, L.; Wedenoja, J.; Dunham, I.; Neale, B.M.; Palta, P.; Hamalainen, E.; Schürks, M.; Rose, L.M.; Buring, J.E.; Ridker, P.M.; Steinberg, S.; Stefansson, H.; Jakobsson, F.; Lawlor, D.A.; Evans, D.M.; Ring, S.M.; Färkkilä, M.; Artto, V.; Kaunisto, M.A.; Freilinger, T.; Schoenen, J.; Frants, R.R.; Pelzer, N.; Weller, C.M.; Zielman, R.; Heath, A.C.; Madden, P.A.F.; Montgomery, G.W.; Martin, N.G.; Borck, G.; Göbel, H.; Heinze, A.; Heinze-Kuhn, K.; Williams, F.M.K.; Hartikainen, A.L.; Pouta, A.; van den Ende, J.; Uitterlinden, A.G.; Hofman, A.; Amin, N.; Hottenga, J.J.; Vink, J.M.; Heikkilä, K.; Alexander, M.; Muller-Myhsok, B.; Schreiber, S.; Meitinger, T.; Wichmann, H.E.; Aromaa, A.; Eriksson, J.G.; Traynor, B.; Trabzuni, D.; Rossin, E.; Lage, K.; Jacobs, S.B.R.; Gibbs, J.R.; Birney, E.; Kaprio, J.; Penninx, B.W.; Boomsma, D.I.; van Duijn, C.; Raitakari, O.; Jarvelin, M.R.; Zwart, J.A.; Cherkas, L.; Strachan, D.P.; Kubisch, C.; Ferrari, M.D.; van den Maagdenberg, A.M.J.M.; Dichgans, M.; Wessman, M.; Smith, G.D.; Stefansson, K.; Daly, M.J.; Nyholt, D.R.; Chasman, D.; Palotie, A. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat. Genet., 2013, 45(8), 912-917.
[http://dx.doi.org/10.1038/ng.2676] [PMID: 23793025]
[40]
Freilinger, T.; Anttila, V.; de Vries, B.; Malik, R.; Kallela, M.; Terwindt, G.M.; Pozo-Rosich, P.; Winsvold, B.; Nyholt, D.R.; van Oosterhout, W.P.; Artto, V.; Todt, U.; Hämäläinen, E.; Fernández-Morales, J.; Louter, M.A.; Kaunisto, M.A.; Schoenen, J.; Raitakari, O.; Lehtimäki, T.; Vila-Pueyo, M.; Göbel, H.; Wichmann, E.; Sintas, C.; Uitterlinden, A.G.; Hofman, A.; Rivadeneira, F.; Heinze, A.; Tronvik, E.; van Duijn, C.M.; Kaprio, J.; Cormand, B.; Wessman, M.; Frants, R.R.; Meitinger, T.; Müller-Myhsok, B.; Zwart, J.A.; Färkkilä, M.; Macaya, A.; Ferrari, M.D.; Kubisch, C.; Palotie, A.; Dichgans, M.; van den Maagdenberg, A.M. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet., 2012, 44(7), 777-782.
[http://dx.doi.org/10.1038/ng.2307] [PMID: 22683712]
[41]
Anttila, V.; Stefansson, H.; Kallela, M.; Todt, U.; Terwindt, G.M.; Calafato, M.S.; Nyholt, D.R.; Dimas, A.S.; Freilinger, T.; Müller-Myhsok, B.; Artto, V.; Inouye, M.; Alakurtti, K.; Kaunisto, M.A.; Hämäläinen, E.; de Vries, B.; Stam, A.H.; Weller, C.M.; Heinze, A.; Heinze-Kuhn, K.; Goebel, I.; Borck, G.; Göbel, H.; Steinberg, S.; Wolf, C.; Björnsson, A.; Gudmundsson, G.; Kirchmann, M.; Hauge, A.; Werge, T.; Schoenen, J.; Eriksson, J.G.; Hagen, K.; Stovner, L.; Wichmann, H.E.; Meitinger, T.; Alexander, M.; Moebus, S.; Schreiber, S.; Aulchenko, Y.S.; Breteler, M.M.; Uitterlinden, A.G.; Hofman, A.; van Duijn, C.M.; Tikka-Kleemola, P.; Vepsäläinen, S.; Lucae, S.; Tozzi, F.; Muglia, P.; Barrett, J.; Kaprio, J.; Färkkilä, M.; Peltonen, L.; Stefansson, K.; Zwart, J.A.; Ferrari, M.D.; Olesen, J.; Daly, M.; Wessman, M.; van den Maagdenberg, A.M.; Dichgans, M.; Kubisch, C.; Dermitzakis, E.T.; Frants, R.R.; Palotie, A. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet., 2010, 42(10), 869-873.
[http://dx.doi.org/10.1038/ng.652] [PMID: 20802479]
[42]
Cox, H.C.; Lea, R.A.; Bellis, C.; Carless, M.; Dyer, T.D.; Curran, J.; Charlesworth, J.; Macgregor, S.; Nyholt, D.; Chasman, D.; Ridker, P.M.; Schürks, M.; Blangero, J.; Griffiths, L.R. A genome-wide analysis of ‘Bounty’ descendants implicates several novel variants in migraine susceptibility. Neurogenetics, 2012, 13(3), 261-266.
[http://dx.doi.org/10.1007/s10048-012-0325-x] [PMID: 22678113]
[43]
Pellacani, S.; Sicca, F.; Di Lorenzo, C.; Grieco, G.S.; Valvo, G.; Cereda, C.; Rubegni, A.; Santorelli, F.M. The Revolution in migraine genetics: from aching channels disorders to a next-generation medicine. Front. Cell. Neurosci., 2016, 10, 156.
[http://dx.doi.org/10.3389/fncel.2016.00156] [PMID: 27378853]
[44]
Esserlind, A.L.; Christensen, A.F.; Steinberg, S.; Grarup, N.; Pedersen, O.; Hansen, T.; Werge, T.; Hansen, T.F.; Husemoen, L.L.; Linneberg, A.; Budtz-Jorgensen, E.; Westergaard, M.L.; Stefansson, H.; Olesen, J. The association between candidate migraine susceptibility loci and severe migraine phenotype in a clinical sample. Cephalalgia, 2016, 36(7), 615-623.
[http://dx.doi.org/10.1177/0333102415570492] [PMID: 25667298]
[45]
Chasman, D.I.; Anttila, V.; Buring, J.E.; Ridker, P.M.; Schürks, M.; Kurth, T. Selectivity in genetic association with sub-classified migraine in women. PLoS Genet., 2014, 10(5)e1004366
[http://dx.doi.org/10.1371/journal.pgen.1004366] [PMID: 24852292]
[46]
Russell, M.B.; Ducros, A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol., 2011, 10(5), 457-470.
[http://dx.doi.org/10.1016/S1474-4422(11)70048-5] [PMID: 21458376]
[47]
Tottene, A.; Fellin, T.; Pagnutti, S.; Luvisetto, S.; Striessnig, J.; Fletcher, C.; Pietrobon, D. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. USA, 2002, 99(20), 13284-13289.
[http://dx.doi.org/10.1073/pnas.192242399] [PMID: 12235360]
[48]
Pietrobon, D. Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine. J. Physiol., 2010, 588(Pt 11), 1871-1878.
[http://dx.doi.org/10.1113/jphysiol.2010.188003] [PMID: 20194127]
[49]
Plomp, J.J.; van den Maagdenberg, A.M.; Molenaar, P.C.; Frants, R.R.; Ferrari, M.D. Mutant P/Q-type calcium channel electrophysiology and migraine. Curr. Opin. Investig. Drugs, 2001, 2(9), 1250-1260.
[PMID: 11717812]
[50]
Kirchmann, M.; Thomsen, L.L.; Olesen, J. The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2006, 141B(3), 250-256.
[http://dx.doi.org/10.1002/ajmg.b.30277] [PMID: 16508934]
[51]
Noble-Topham, S.E.; Dyment, D.A.; Cader, M.Z.; Ganapathy, R.; Brown, J.D.; Rice, G.P.; Ebers, G.C. Migraine with aura is not linked to the FHM gene CACNA1A or the chromosomal region, 19p13. Neurology, 2002, 59(7), 1099-1101.
[http://dx.doi.org/10.1212/WNL.59.7.1099] [PMID: 12370474]
[52]
Barros, J.; Damásio, J.; Tuna, A.; Alves, I.; Silveira, I.; Pereira-Monteiro, J.; Sequeiros, J.; Alonso, I.; Sousa, A.; Coutinho, P. Cerebellar ataxia, hemiplegic migraine, and related phenotypes due to a CACNA1A missense mutation: 12-year follow-up of a large Portuguese family. JAMA Neurol., 2013, 70(2), 235-240.
[http://dx.doi.org/10.1001/jamaneurol.2013.591] [PMID: 23407676]
[53]
Lebas, A.; Guyant-Marechal, L.; Hannequin, D.; Riant, F.; Tournier-Lasserve, E.; Parain, D. Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia, 2008, 28(7), 774-777.
[http://dx.doi.org/10.1111/j.1468-2982.2008.01603.x]
[54]
Pelzer, N.; Haan, J.; Stam, A.H.; Vijfhuizen, L.S.; Koelewijn, S.C.; Smagge, A.; de Vries, B.; Ferrari, M.D.; van den Maagdenberg, A.M.J.M.; Terwindt, G.M. Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology, 2018, 90(7), e575-e582.
[http://dx.doi.org/10.1212/WNL.0000000000004966] [PMID: 29343472]
[55]
Friedrich, T.; Tavraz, N.N.; Junghans, C. ATP1A2 Mutations in migraine: seeing through the facets of an ion pump onto the neurobiology of disease. Front. Physiol., 2016, 7, 239.
[http://dx.doi.org/10.3389/fphys.2016.00239] [PMID: 27445835]
[56]
Prontera, P.; Sarchielli, P.; Caproni, S.; Bedetti, C.; Cupini, L.M.; Calabresi, P.; Costa, C. Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications. Cephalalgia, 2018, 38(2), 361-373.
[http://dx.doi.org/10.1177/0333102416686347] [PMID: 28058944]
[57]
Harkin, L.A.; McMahon, J.M.; Iona, X.; Dibbens, L.; Pelekanos, J.T.; Zuberi, S.M.; Sadleir, L.G.; Andermann, E.; Gill, D.; Farrell, K.; Connolly, M.; Stanley, T.; Harbord, M.; Andermann, F.; Wang, J.; Batish, S.D.; Jones, J.G.; Seltzer, W.K.; Gardner, A.; Sutherland, G.; Berkovic, S.F.; Mulley, J.C.; Scheffer, I.E.; Scheffer, I.E. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain, 2007, 130(Pt 3), 843-852.
[http://dx.doi.org/10.1093/brain/awm002] [PMID: 17347258]
[58]
Verbeek, N.E.; van Kempen, M.; Gunning, W.B.; Renier, W.O.; Westland, B.; Lindhout, D.; Brilstra, E.H. Adults with a history of possible Dravet syndrome: an illustration of the importance of analysis of the SCN1A gene. Epilepsia, 2011, 52(4), e23-e25.
[http://dx.doi.org/10.1111/j.1528-1167.2011.02982.x] [PMID: 21371021]
[59]
Fan, C.; Wolking, S.; Lehmann-Horn, F.; Hedrich, U.B.; Freilinger, T.; Lerche, H.; Borck, G.; Kubisch, C.; Jurkat-Rott, K. Early-onset familial hemiplegic migraine due to a novel SCN1A mutation. Cephalalgia, 2016, 36(13), 1238-1247.
[http://dx.doi.org/10.1177/0333102415608360] [PMID: 26763045]
[60]
Weller, C.M.; Pelzer, N.; de Vries, B.; López, M.A.; De Fàbregues, O.; Pascual, J.; Arroyo, M.A.; Koelewijn, S.C.; Stam, A.H.; Haan, J.; Ferrari, M.D.; Terwindt, G.M.; van den Maagdenberg, A.M. Two novel SCN1A mutations identified in families with familial hemiplegic migraine. Cephalalgia, 2014, 34(13), 1062-1069.
[http://dx.doi.org/10.1177/0333102414529195] [PMID: 24707016]
[61]
Callejo, G.; Giblin, J.P.; Gasull, X. Modulation of TRESK background K+ channel by membrane stretch. PLoS One, 2013, 8(5)e64471
[http://dx.doi.org/10.1371/journal.pone.0064471] [PMID: 23691227]
[62]
Dobler, T.; Springauf, A.; Tovornik, S.; Weber, M.; Schmitt, A.; Sedlmeier, R.; Wischmeyer, E.; Döring, F. TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones. J. Physiol., 2007, 585(Pt 3), 867-879.
[http://dx.doi.org/10.1113/jphysiol.2007.145649] [PMID: 17962323]
[63]
Andres-Enguix, I.; Shang, L.; Stansfeld, P.J.; Morahan, J.M.; Sansom, M.S.; Lafrenière, R.G.; Roy, B.; Griffiths, L.R.; Rouleau, G.A.; Ebers, G.C.; Cader, Z.M.; Tucker, S.J. Functional analysis of missense variants in the TRESK (KCNK18) K channel. Sci. Rep., 2012, 2, 237.
[http://dx.doi.org/10.1038/srep00237] [PMID: 22355750]
[64]
Rainero, I.; Rubino, E.; Gallone, S.; Zavarise, P.; Carli, D.; Boschi, S.; Fenoglio, P.; Savi, L.; Gentile, S.; Benna, P.; Pinessi, L.; Dalla Volta, G. KCNK18 (TRESK) genetic variants in Italian patients with migraine. Headache, 2014, 54(9), 1515-1522.
[http://dx.doi.org/10.1111/head.12439] [PMID: 25324165]
[65]
Joutel, A.; Corpechot, C.; Ducros, A.; Vahedi, K.; Chabriat, H.; Mouton, P.; Alamowitch, S.; Domenga, V.; Cécillion, M.; Marechal, E.; Maciazek, J.; Vayssiere, C.; Cruaud, C.; Cabanis, E.A.; Ruchoux, M.M.; Weissenbach, J.; Bach, J.F.; Bousser, M.G.; Tournier-Lasserve, E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 1996, 383(6602), 707-710.
[http://dx.doi.org/10.1038/383707a0] [PMID: 8878478]
[66]
Monet-Leprêtre, M.; Bardot, B.; Lemaire, B.; Domenga, V.; Godin, O.; Dichgans, M.; Tournier-Lasserve, E.; Cohen-Tannoudji, M.; Chabriat, H.; Joutel, A. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain, 2009, 132(Pt 6), 1601-1612.
[http://dx.doi.org/10.1093/brain/awp049] [PMID: 19293235]
[67]
Meng, H.; Zhang, X.; Yu, G.; Lee, S.J.; Chen, Y.E.; Prudovsky, I.; Wang, M.M. Biochemical characterization and cellular effects of CADASIL mutants of NOTCH3. PLoS One, 2012, 7(9)e44964
[http://dx.doi.org/10.1371/journal.pone.0044964] [PMID: 23028706]
[68]
Di Donato, I.; Bianchi, S.; De Stefano, N.; Dichgans, M.; Dotti, M.T.; Duering, M.; Jouvent, E.; Korczyn, A.D.; Lesnik-Oberstein, S.A.; Malandrini, A.; Markus, H.S.; Pantoni, L.; Penco, S.; Rufa, A.; Sinanović, O.; Stojanov, D.; Federico, A. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med., 2017, 15(1), 41.
[http://dx.doi.org/10.1186/s12916-017-0778-8] [PMID: 28231783]
[69]
Rubino, E.; Fenoglio, P.; Gallone, S.; Govone, F.; Vacca, A.; De Martino, P.; Giobbe, M.L.; Boschi, S.; Pinessi, L.; Gentile, S.; Rainero, I. Genetic variants in the NOTCH4 gene influence the clinical features of migraine. J. Headache Pain, 2013, 14, 28.
[http://dx.doi.org/10.1186/1129-2377-14-28] [PMID: 23566281]
[70]
Rossi, P.; Sterlini, B.; Castroflorio, E.; Marte, A.; Onofri, F.; Valtorta, F.; Maragliano, L.; Corradi, A.; Benfenati, F. A novel topology of Proline-rich Transmembrane Protein 2 (PRRT2): HINTS FOR AN INTRACELLULAR FUNCTION AT THE SYNAPSE. J. Biol. Chem., 2016, 291(12), 6111-6123.
[http://dx.doi.org/10.1074/jbc.M115.683888] [PMID: 26797119]
[71]
Pelzer, N.; de Vries, B.; Kamphorst, J.T.; Vijfhuizen, L.S.; Ferrari, M.D.; Haan, J.; van den Maagdenberg, A.M.; Terwindt, G.M. PRRT2 and hemiplegic migraine: a complex association. Neurology, 2014, 83(3), 288-290.
[http://dx.doi.org/10.1212/WNL.0000000000000590] [PMID: 24928127]
[72]
Cevoli, S.; Giannini, G.; Favoni, V.; Pierangeli, G.; Cortelli, P. Migraine and sleep disorders. Neurol. Sci., 2012, 33(Suppl. 1), S43-S46.
[http://dx.doi.org/10.1007/s10072-012-1030-0] [PMID: 22644169]
[73]
McCully, K.S. Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann. Clin. Lab. Sci., 2009, 39(3), 219-232.
[PMID: 19667406]
[74]
Dionisio, N.; Jardín, I.; Salido, G.M.; Rosado, J.A. Homocysteine, intracellular signaling and thrombotic disorders. Curr. Med. Chem., 2010, 17(27), 3109-3119.
[http://dx.doi.org/10.2174/092986710791959783] [PMID: 20629621]
[75]
Zieminska, E.; Lazarewicz, J.W. Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol. Exp. (Warsz.), 2006, 66(4), 301-309.
[PMID: 17265692]
[76]
Yeganeh, F.; Nikbakht, F.; Bahmanpour, S.; Rastegar, K.; Namavar, R. Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study. J. Mol. Neurosci., 2013, 50(3), 551-557.
[http://dx.doi.org/10.1007/s12031-013-9996-5] [PMID: 23564299]
[77]
Frosst, P.; Blom, H.J.; Milos, R.; Goyette, P.; Sheppard, C.A.; Matthews, R.G.; Boers, G.J.; den Heijer, M.; Kluijtmans, L.A.; van den Heuvel, L.P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 1995, 10(1), 111-113.
[http://dx.doi.org/10.1038/ng0595-111] [PMID: 7647779]
[78]
Samaan, Z.; Gaysina, D.; Cohen-Woods, S.; Craddock, N.; Jones, L.; Korszun, A.; Owen, M.; Mente, A.; McGuffin, P.; Farmer, A. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol., 2011, 11, 66.
[http://dx.doi.org/10.1186/1471-2377-11-66] [PMID: 21635773]
[79]
Liu, A.; Menon, S.; Colson, N.J.; Quinlan, S.; Cox, H.; Peterson, M.; Tiang, T.; Haupt, L.M.; Lea, R.A.; Griffiths, L.R. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res. Notes, 2010, 3, 213.
[http://dx.doi.org/10.1186/1756-0500-3-213] [PMID: 20663228]
[80]
Liu, R.; Geng, P.; Ma, M.; Yu, S.; Yang, M.; He, M.; Dong, Z.; Zhang, W. MTHFR C677T polymorphism and migraine risk: a meta-analysis. J. Neurol. Sci., 2014, 336(1-2), 68-73.
[http://dx.doi.org/10.1016/j.jns.2013.10.008] [PMID: 24183284]
[81]
Schürks, M.; Rist, P.M.; Kurth, T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache, 2010, 50(4), 588-599.
[http://dx.doi.org/10.1111/j.1526-4610.2009.01570.x] [PMID: 19925624]
[82]
Rubino, E.; Ferrero, M.; Rainero, I.; Binello, E.; Vaula, G.; Pinessi, L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia, 2009, 29(8), 818-825.
[http://dx.doi.org/10.1111/j.1468-2982.2007.01400.x] [PMID: 17714520]
[83]
Azimova, J.E.; Sergeev, A.V.; Korobeynikova, L.A.; Kondratieva, N.S.; Kokaeva, Z.G.; Shaikhaev, G.O.; Skorobogatykh, K.V.; Fokina, N.M.; Tabeeva, G.R.; Klimov, E.A. Effects of MTHFR gene polymorphism on the clinical and electrophysiological characteristics of migraine. BMC Neurol., 2013, 13, 103.
[http://dx.doi.org/10.1186/1471-2377-13-103] [PMID: 23915182]
[84]
Bahadir, A.; Eroz, R.; Dikici, S. Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue. Cell. Mol. Neurobiol., 2013, 33(8), 1055-1063.
[http://dx.doi.org/10.1007/s10571-013-9972-1] [PMID: 23975093]
[85]
Magis, D.; Allena, M.; Coppola, G.; Di Clemente, L.; Gérard, P.; Schoenen, J. Search for correlations between genotypes and electrophysiological patterns in migraine: the MTHFR C677T polymorphism and visual evoked potentials. Cephalalgia, 2007, 27(10), 1142-1149.
[http://dx.doi.org/10.1111/j.1468-2982.2007.01412.x] [PMID: 17711493]
[86]
de Tommaso, M.; Difruscolo, O.; Sardaro, M.; Losito, L.; Serpino, C.; Pietrapertosa, A.; Santeramo, M.T.; Dicuonzo, F.; Carella, A.; Lamberti, P.; Livrea, P. Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine. Headache, 2007, 47(2), 253-265.
[http://dx.doi.org/10.1111/j.1526-4610.2006.00690.x] [PMID: 17300365]
[87]
Lea, R.; Colson, N.; Quinlan, S.; Macmillan, J.; Griffiths, L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet. Genomics, 2009, 19(6), 422-428.
[http://dx.doi.org/10.1097/FPC.0b013e32832af5a3] [PMID: 19384265]
[88]
Lesch, K.P.; Bengel, D.; Heils, A.; Sabol, S.Z.; Greenberg, B.D.; Petri, S.; Benjamin, J.; Müller, C.R.; Hamer, D.H.; Murphy, D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 1996, 274(5292), 1527-1531.
[http://dx.doi.org/10.1126/science.274.5292.1527] [PMID: 8929413]
[89]
Chang, C.C.; Chang, H.A.; Fang, W.H.; Chang, T.C.; Huang, S.Y. Gender-specific association between serotonin transporter polymorphisms (5-HTTLPR and rs25531) and neuroticism, anxiety and depression in well-defined healthy Han Chinese. J. Affect. Disord., 2017, 207, 422-428.
[http://dx.doi.org/10.1016/j.jad.2016.08.055] [PMID: 27788383]
[90]
Schürks, M.; Rist, P.M.; Kurth, T. 5-HTTLPR polymorphism in the serotonin transporter gene and migraine: a systematic review and meta-analysis. Cephalalgia, 2010, 30(11), 1296-1305.
[http://dx.doi.org/10.1177/0333102410362929] [PMID: 20959425]
[91]
Kraya, T.; Deschauer, M.; Joshi, P.R.; Zierz, S.; Gaul, C. Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study. Headache, 2018, 58(1), 45-52.
[http://dx.doi.org/10.1111/head.13219] [PMID: 29139113]
[92]
Yorns, W.R., Jr; Hardison, H.H. Mitochondrial dysfunction in migraine. Semin. Pediatr. Neurol., 2013, 20(3), 188-193.
[http://dx.doi.org/10.1016/j.spen.2013.09.002] [PMID: 24331360]
[93]
Vollono, C.; Primiano, G.; Della Marca, G.; Losurdo, A.; Servidei, S. Migraine in mitochondrial disorders: Prevalence and characteristics. Cephalalgia, 2018, 38(6), 1093-1106.
[http://dx.doi.org/10.1177/0333102417723568] [PMID: 28762753]
[94]
Stuart, S.; Benton, M.C.; Eccles, D.A.; Sutherland, H.G.; Haupt, L.M.; Lea, R.A.; Griffiths, L.R. Gene-centric analysis implicates nuclear encoded mitochondrial protein gene variants in migraine susceptibility. Mol. Genet. Genomic Med., 2017, 5(2), 157-163.
[http://dx.doi.org/10.1002/mgg3.270]

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy